Notice 1 May 2025 dea, drug enforcement, regulatory compliance, controlled substances, pharmaceutical industry

💊Importer of Controlled Substances Application by US Pharmacopeial Convention

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 1 May 2025 fda, compliance, user fees, prescription drugs, business regulation, pharmaceutical industry

💊FDA Notice on Prescription Drug User Fee Program Details

The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Learn More
Notice 28 Apr 2025 manufacturing, controlled substances, pharmaceutical industry, compliance, dea, drug regulation

💊Bulk Manufacturer Registration Application by Pisgah Laboratories

Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, pharmaceutical industry, compliance, clinical trials, drug enforcement

💊Almac Clinical Services' Importer Application for Controlled Substances

Almac Clinical Services, Inc., (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 pharmaceutical industry, regulation, compliance, controlled substances, importation, dea, usa

💊DEA Notice on Royal Emerald Pharmaceuticals' Import Application

Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 controlled substances, pharmaceutical industry, drug enforcement, regulatory compliance, manufacturing

💊Patheon API Services Inc. Applies for Controlled Substances Registration

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 14 Apr 2025 regulatory compliance, dea, pharmaceutical industry, texas, controlled substances

💊DEA Revokes Eagle Pharmacy Registration

The Drug Enforcement Administration issued an Order to Show Cause against Eagle Pharmacy for alleged violations related to dispensing controlled substances without addressing significant red flags of abuse. The case highlights the stringent regulations governing pharmacies and the potential consequences of non-compliance, including revocation of licenses and operational disruptions.

Learn More
Notice 27 Mar 2025 regulatory compliance, pharmaceutical industry, dea, controlled substances, business registration

💊SpecGx LLC Controlled Substances Import Application Overview

SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 26 Feb 2025 pharmaceutical industry, compliance, controlled substances, s&b pharma, drug enforcement, dea

💊Notice of S&B Pharma's Application for Controlled Substances Import

S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Feb 2025 compliance, business regulation, research, pharmaceutical industry, controlled substances, drug enforcement

💊Notice of Application for Bulk Manufacturing of Controlled Substances

Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More